TWI319324B - The use of anti-estrogens for the prevention and treatment of androgen-deprivation induced osteoporosis, loss of bone mineral density and/or bone fractures in males subjects with prostate cancer - Google Patents

The use of anti-estrogens for the prevention and treatment of androgen-deprivation induced osteoporosis, loss of bone mineral density and/or bone fractures in males subjects with prostate cancer

Info

Publication number
TWI319324B
TWI319324B TW94124310A TW94124310A TWI319324B TW I319324 B TWI319324 B TW I319324B TW 94124310 A TW94124310 A TW 94124310A TW 94124310 A TW94124310 A TW 94124310A TW I319324 B TWI319324 B TW I319324B
Authority
TW
Taiwan
Prior art keywords
estrogens
androgen
prevention
loss
treatment
Prior art date
Application number
TW94124310A
Other languages
Chinese (zh)
Other versions
TW200536555A (en
Inventor
Mitchell S Steiner
Original Assignee
Gtx Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Gtx Inc filed Critical Gtx Inc
Priority to TW94124310A priority Critical patent/TWI319324B/en
Publication of TW200536555A publication Critical patent/TW200536555A/en
Application granted granted Critical
Publication of TWI319324B publication Critical patent/TWI319324B/en

Links

TW94124310A 2002-12-16 2002-12-16 The use of anti-estrogens for the prevention and treatment of androgen-deprivation induced osteoporosis, loss of bone mineral density and/or bone fractures in males subjects with prostate cancer TWI319324B (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
TW94124310A TWI319324B (en) 2002-12-16 2002-12-16 The use of anti-estrogens for the prevention and treatment of androgen-deprivation induced osteoporosis, loss of bone mineral density and/or bone fractures in males subjects with prostate cancer

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
TW94124310A TWI319324B (en) 2002-12-16 2002-12-16 The use of anti-estrogens for the prevention and treatment of androgen-deprivation induced osteoporosis, loss of bone mineral density and/or bone fractures in males subjects with prostate cancer

Publications (2)

Publication Number Publication Date
TW200536555A TW200536555A (en) 2005-11-16
TWI319324B true TWI319324B (en) 2010-01-11

Family

ID=45073617

Family Applications (1)

Application Number Title Priority Date Filing Date
TW94124310A TWI319324B (en) 2002-12-16 2002-12-16 The use of anti-estrogens for the prevention and treatment of androgen-deprivation induced osteoporosis, loss of bone mineral density and/or bone fractures in males subjects with prostate cancer

Country Status (1)

Country Link
TW (1) TWI319324B (en)

Also Published As

Publication number Publication date
TW200536555A (en) 2005-11-16

Similar Documents

Publication Publication Date Title
TWI315987B (en) The use of toremifene for the prevention and treatment of androgen-deprivation induced osteoporosis, loss of bone mineral density and/or bone fractures in males subjects with prostate cancer
IL158273A0 (en) Use of bisphosphonates in the treatment of bone metastasis associated with prostate cancer
EP1487436A4 (en) Combination therapy for treating, preventing or managing proliferative disorders and cancers
EP1465997A4 (en) Use of biomolecular targets in the treatment and visualization of tumors
HK1080840A1 (en) Arylcarbonylpiperazines and heteroarylcarbonylpiperazines and the use thereof for treating benign and malignant tumour diseases
EP1495130A4 (en) Use of biomolecular targets in the treatment and visualization of brain tumors
EP1487492A4 (en) The prevention or treatment of cancer using integrin alphavbeta3 antagonists in combination with other agents
AU2003237367A8 (en) Use of nrg4, or inhibitors thereof, in the treatment of colon and pancreatic cancer
HK1086488A1 (en) Compound and use thereof for the treatment of cancer
GB0109537D0 (en) Well treatment fluids and methods for the use thereof
HUP0104688A3 (en) Compositions and methods for the prevention or treatment of cancer and bone loss associated with cancer
HUP0401903A3 (en) Improved use of et-743 in cancer thereapy
EP1567556A4 (en) Recombinant immunotoxin and use in treating tumors
HUP0300339A3 (en) Use of fulvestrant in the treatment of resistant breast cancer
AU2002340251A8 (en) Use of mx gtpases in the prognosis and treatment of cancer
MXPA03000984A (en) Methods of treating cancer and the pain associated therewith using endothelin antagonists.
TWI319324B (en) The use of anti-estrogens for the prevention and treatment of androgen-deprivation induced osteoporosis, loss of bone mineral density and/or bone fractures in males subjects with prostate cancer
AU2003250831A8 (en) Use of hec1 antagonists in the treatment of proliferative disorders and cancer
EP1383543A4 (en) Use of biomolecular targets in the treatment and visualization of brain tumors
AU2002366195A8 (en) Use of bisindolmaleimide and gemcitabine for the treatment of cancer
IL150527A0 (en) Use of vitamin d-derivatives in the treatment of osteoporosis and related bone disorders, as well as novel vitamin d3-derivatives
EP1684795A4 (en) Methods and agents for the treatment of cancer
EP1646385A4 (en) Use of benzothiopenes to treat and prevent prostate cancer
AU2002366364A8 (en) E2f and cancer therapy
AU2003209265A8 (en) Mrp9 and its use detecting and treating cancer

Legal Events

Date Code Title Description
MM4A Annulment or lapse of patent due to non-payment of fees